IPO registrations (S-1, F-1) · Registrants

Evommune, Inc.

SEC CIK
2044725 · filings on EDGAR ↗
Registration
Form S-1, first filed 2025-10-09, last 2026-04-17; 2 initial registrations, 1 amendment
Outcome
Final prospectus filed 2025-11-06; declared effective 2026-04-24
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1891 PAGE MILL RD, Palo Alto, CA
EIN
85-0742575
Ticker
EVMN (NYSE)
EDGAR entity type
operating
Insiders and CEO pay
Evommune, Inc. on the corporate pages

Offering terms

Proposed price range
$15.00–$17.00 per share (S-1/A filed 2025-10-17)
Final price
$16.00 per share, within the range (424B4 filed 2025-11-06, an initial public offering)
Shares sold
9,375,000
Gross proceeds
$150,000,000 before underwriting discounts and any over-allotment option
Listing
NYSE under the symbol EVMN
Lead underwriters
Morgan Stanley; Leerink Partners (2,625,000 shares); Evercore (1,968,750 shares); Cantor Fitzgerald (1,312,500 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 5

FiledFormWhat it isName as filedEDGAR
2025-10-09S-1S-1 (registration)Evommune, Inc.0001193125-25-235673 ↗
2025-10-17S-1/AS-1/A (amendment)Evommune, Inc.0001193125-25-242492 ↗
2025-11-06424B4424B4 (final prospectus)Evommune, Inc.0001193125-25-270066 ↗
2026-04-17S-1S-1 (registration)Evommune, Inc.0001193125-26-161516 ↗
2026-04-24EFFECTEFFECT (declared effective)Evommune, Inc.9999999995-26-001330 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2025-10-17S-1/Aregistration statement$15.00–$17.009,375,000-NYSE EVMN4primary document; range, shares headline, cover names 4document ↗
2025-11-06424B4final prospectus$16.009,375,000$150,000,000NYSE EVMN4primary document; price sentence, shares sentence, proceeds table, underwriting table 3, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bauer EugeneDirector,OfficerChief Medical Officer52025–2026
Carver KyleOfficerChief Financial Officer72025–2026
Cohen David EDirector42025–2026
DiRocco DerekDirector12025
Drew Janice SuzannOfficerChief of Dev. Operations; EVP, Operations62025–2026
Hopfner Robert LorneDirector,TenPercentOwner32025
KIRSCH ARTHUR SDirector42025–2026
Kolchinsky PeterDirector; Director,TenPercentOwner22025–2026
LSP 7 Cooperative UADirector,TenPercentOwner; TenPercentOwner32025–2026
MCGRAW BENJAMIN F IIIDirector32025–2026
Moss Gregory S.OfficerChief Business & Legal Officer62025–2026
Patel Jeegar PravinkumarOfficerChief Scientific Officer72025–2026
Pena Luis C.Director,OfficerPresident & CEO72025–2026person page Fuzzy
Pivotal bioVenture Partners Fund I G.P., L.P.Director,TenPercentOwner22025
Pivotal bioVenture Partners Fund I, L.P.Director,TenPercentOwner22025
Pivotal bioVenture Partners Fund I U.G.P. LtdDirector,TenPercentOwner22025
RA Capital Healthcare Fund LPDirector; Director,TenPercentOwner22025–2026
RA CAPITAL MANAGEMENT, L.P.Director; Director,TenPercentOwner32025–2026
RA Capital Nexus Fund III, L.P.Director22025–2026
Shah Rajeev M.Director; Director,TenPercentOwner22025–2026
Verduyn-van Weegen Felice IsabelDirector,TenPercentOwner32025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2025-01-08Evommune, Inc.Other$115,499,956$115,499,956251
2025-01-08Evommune, Inc.Other$57,500,000$57,500,000161
2025-01-08Evommune, Inc.Other$84,449,985$81,799,952101
2025-01-07Evommune, Inc.Other$12,462,474$12,462,474181

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorEVOMMUNE, INC.CAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerEvommune, Inc.CAForm D private offeringsCIK (EXACT)
SEC filerEvommune, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerEvommune, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorEVOMMUNE, INC.EIN (EXACT)
Person pageLuis C PenaPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health